Input is being solicited by the US Food and Drug Administration on how best to prioritize the addition of maximum daily exposure information to its inactive ingredient database, as well as potentially modifying the IID structure to eliminate dosage form information.
Interested parties have until 21 June to submit comments to the FDA either electronically or in writing, with full details...